COVID-19 COVID-19 Vaccine Public Health 
Bill of Health
NOVEMBER 8, 2022
In June 2022, after almost two years of debate over a potential COVID-19 vaccine patent waiver, the World Trade Organization adopted the Ministerial Decision on the TRIPS Agreement (“WTO Decision”), which provided for a partial waiver of intellectual property rights. appeared first on Bill of Health. By Sarah Gabriele.
Bill of Health
JANUARY 12, 2023
Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. Interestingly, as of January 12, 2023, Moderna has listed 10 patents covering Spikevax (its mRNA vaccine) on its website.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare Dive
DECEMBER 13, 2022
The vaccines also reduced infections and hospitalizations, which freed up hospital resources, researchers at the Commonwealth Fund and Yale School of Public Health concluded.
Healthcare It News
OCTOBER 22, 2021
As communities across the nation seek new ways to bring COVID-19 vaccination rates up to levels that can more effectively mitigate the spread of variants, they are looking for new and better ways to reach those who are just hesitant, undecided or unaware of how to get vaccinated. Ninety-seven percent of adults in the U.S.
Bill of Health
JANUARY 18, 2022
The Court placed COVID-19 in the latter category. Per the Court, such an approach would take “on the character of a general public health measure, rather than an ‘ occupational safety or health standard'” that falls within OSHA’s authority to establish. The CMS Case.
Healthcare It News
NOVEMBER 25, 2021
In the control group, which received only brief information about the COVID-19 vaccination, there were no comparable results in terms of general views and willingness to vaccinate. In other parts of Europe, especially in the south-west, the vaccination rates are significantly lower than 50 per cent.
Bill of Health
AUGUST 29, 2022
On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. In short, these public statements, if made in a manner that is intended to be taken seriously (e.g., Pandemic Pledges. Moderna’s Pledge.
Expert insights. Personalized for you.
311 
Let's personalize your content